Product Description
Mechanisms of Action: Gram- Bacteria Degrader
Novel Mechanism: Yes
Modality: Coagulation Factor
Route of Administration: Intravenous
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: XOMA
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
Countries in Clinic: